Originator Organization Symeres BVStartup |
Active Organization Symeres BVStartup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | NL | Symeres BVStartup | 02 Feb 2024 |